Clarivate Annual G20 Scorecard Examines Global Research and Innovation Trends Across G20 Members

July 16, 2024 08:00 AM BST | By Cision
 Clarivate Annual G20 Scorecard Examines Global Research and Innovation Trends Across G20 Members
Image source: Kalkine Media

Dynamic, interactive data visualizations reveal comprehensive view of the global research and innovation landscape

LONDON, July 16, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released its annual G20 scorecard, compiled by expert analysts and data scientists at the Institute for Scientific Information (ISI)™. The annual G20 research and innovation scorecard examines the research and innovation capabilities of each G20 member through dynamic, interactive data visualizations. This year, for the first time, the report includes data for the European Union and the G20's new permanent member, the African Union.

The scorecard is designed for the responsible evaluation of the research and innovation capabilities of the G20 members, including new data points that illuminate collaborative impact and demonstrate the effect of research and innovation on society in the form of patent to paper citations. It also contains expanded analyses of data on the research focused on the UN Sustainable Development Goals (SDGs), examining the collaborative and accessible nature of this research. It publishes ahead of the G20 summit in Rio de Janeiro, Brazil on November 18-19 and is freely available to explore on Clarivate.com.

Emmanuel Thiveaud, Senior Vice President for Research & Analytics, Academia & Government at Clarivate said: "We promote responsible research assessment by considering comprehensive profiles and indicators that capture the broad contributions research makes to society in terms of quality and impact."

"The G20 scorecard provides a holistic view of the global research and innovation landscape, highlighting strengths and areas needing improvement within each country and region profiled. For policymakers, governments, funders and research institutions worldwide, it offers reliable evidence to inform critical decisions about research planning and strategic investments."

Gordon Rogers, Senior Manager, Data Science at the Institute for Scientific Information at Clarivate, said: "The inclusion of the European and the African Union in the 2024 scorecard for the first time marks a pivotal expansion in our analysis to reflect a more comprehensive and inclusive view of global research dynamics. This broader perspective allows for a deeper understanding of the diverse and collaborative efforts needed to address global challenges and advance sustainable development goals."

Key findings in the 2024 G20 scorecard include:

  • The African Union (AU) shows a high collaboration rate, collaborations with Mainland China yield higher citation impact than those with the U.S., their leading partner. The AU's SDG priorities are No Poverty (SDG 1) and Gender Equality (SDG 5).
  • The European Union is the largest contributor of papers than any other G20 member. 40% of collaboration is with external partners compared to 10% within the EU. It publishes more open access papers than the G20 average.
  • Germany has a high number of researchers per capita. It exhibits above world average Category Normalized Citation Impact™ (CNCI) for collaborative papers and its Normalized Patent Citation Impact* is around twice the world average in Medicine. More than 60% of papers produced in 2023 were open access.
  • India has seen international collaboration increase to just over one-third (35.6%) over the decade (2014 to 2023), the U.S. is its leading collaborator. Its SDG focus on Economic Growth (SDG 8) and Industry (SDG 9) are the most impactful.
  • Mainland China's international collaborations are mostly bilateral (around three quarters). Its most frequent partner remains the U.S., although the percentage has halved over the decade (2014 – 2023) from 12% to 6%. Its Normalized Patent Citation Impact is above world average.
  • South Korea's collaborations with the U.S. have fallen, while those with Mainland China and India are rising. It also shows high Normalized Patent Citation Impact in Good Health (SDG 3) and Sustainable Cities (SDG 11), at around 1.6 and 1.4 times the world average respectively.
  • United Kingdom's research output has a high citation impact with CNCI at 1.4 times world average; Collaboration rose from below 60% in 2015 to over 70% since 2022, with leading partners in the U.S., Germany and increasingly, Mainland China. Its Normalized Patent Citation Impact is strong in Engineering and Technology, Medicine and Life Sciences.
  • United States exhibits high Normalized Patent Citation Impact in Engineering and Technology, Life Sciences and Medicine. On the UN SDGs, there is a strong focus on Peace & Justice (SDG 16) and Reduced Inequalities (SDG 10) in terms of paper output and a strong focus on Good Health (SDG 3) and Clean Energy (SDG 7) in terms of citation impact from patents.

Notes to editors:
The G20 research and innovation scorecard 2024 is available to explore on the Institute for Scientific Information's page on Clarivate.com, with a freely downloadable executive summary highlighting key findings.

The members of the G20 include: African Union, Argentina, Australia, Brazil, Canada, China (Mainland), European Union, France, Germany, India, Indonesia, Italy, Japan, Mexico, Russia, Saudi Arabia, South Africa, South Korea, Türkiye, the United Kingdom and the United States. The African Union, previously an invited organization, was granted full member status in Delhi, September 2023.

* Mainland China includes data from Hong Kong SAR and Macau SAR

*The Normalized Patent Citation Impact™ measures the number of citations each paper receives from related patents; the total is normalized against the average number of citations received by all papers published in the same year.

About Clarivate
Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com 

Media contact:
Helen Chung-Kesl, External Communications Manager, Academia & Government
[email protected]

 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

AI on the Rise: A Look at Top AI Companies and Their Stocks

Send OTP Resend OTP in 30s
Verify OTP

Sponsored Articles


Investing Ideas

Previous Next